"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to ABVX. [ FAQ on what and how to ask] For non-ABVX questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Mr. Marc M. P. de Garidel M.B.A.
Headquarter: 7-11 Boulevard Haussmann, Paris, France, 75009
Industry: Biotechnology, Investment Track: Biotech - Ulcerative Colitis, Employees: 69
ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
My Watchlist
